mRNA |
GSK2126458 |
GDSC1000 |
pan-cancer |
AAC |
-0.058 |
0.08 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.08 |
mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
-0.056 |
0.08 |
mRNA |
JW-7-24-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.054 |
0.08 |
mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
-0.054 |
0.08 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.08 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.08 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.064 |
0.08 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.08 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.09 |